Vojnosanitetski pregled 2023 Volume 80, Issue 10, Pages: 811-813
https://doi.org/10.2298/VSP2310811J
Full text (
244 KB)
RNA vaccines: A milestone toward a new era
Janković Srđa (University Children’s Hospital, Department of Hematology and Oncology, Division of Immunology, Belgrade, Serbia), srdja.jankovic@udk.bg.ac.rs; ysrdja@gmail.com
Keywords: RNA, vaccines, biotechnology
Show references
Saito H. The RNA world ′hypothesis′. Nat Rev Mol Cell Biol 2022; 23(9): 582.
Fine JL, Pearlman JE. On the origin of life: an RNA-focused synthesis and narrative. RNA 2023; 29(8): 1085-98.
Panni S, Lovering RC, Porras P, Orchard S. Non-coding RNA regulatory networks. Biochim Biophys Acta Gene Regul Mech 2020; 1863(6): 194417.
Villarreal L, Witzany G. Self-empowerment of life through RNA networks, cells and viruses. F1000Research 2023; 12: 138.
Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 2020; 85: 104502.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, et al. Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. N Engl J Med 2021; 385(19): 1774-85.
Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lock-hart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. N Engl J Med 2021; 385(19): 1761-73.
Bartsch SM, Wedlock PT, O’Shea KJ, Cox SN, Strych U, Nuzzo JB, et al. Lives and costs saved by expanding and expediting coronavirus disease 2019 vaccination. J Infect Dis 2021; 224(6): 938-48.
Noor R. mRNA vaccines as an efficient approach for the rapid and robust induction of host immunity against SARS-CoV-2. SN Compr Clin Med 2022; 4(1): 88.
Santi Laurini G, Montanaro N, Broccoli M, Bonaldo G, Motola D. Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database. Vaccine 2023; 41(18): 2879-86.
Blumenthal KG, Greenhawt M, Phillips EJ, Agmon-Levin N, Golden DBK, Shaker M. An update in COVID-19 vaccine reactions in 2023: progress and understanding. J Allergy Clin Immunol Pract 2023; S2213-2198(23)00723-7.
Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, et al. The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. J Allergy Clin Immunol Pract 2021; 9(10): 3546-67.
Wong HL, Hu M, Zhou CK, Lloyd PC, Amend KL, Beachler DC, et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: A cohort study in claims databases. Lancet 2022; 399(10342): 2191-9.
Świerkot J, Madej M, Szmyrka M, Korman L, Sokolik R, Andrasiak I, et al. The risk of autoimmunity development following mRNA COVID-19 vaccination. Viruses 2022; 14(12): 2655.
Janković S. Vaccination and autoimmune phenomena. Central Eur J Paed 2017; 13(1): 12-23.
Toussirot É, Bereau M. Vaccination and induction of autoimmune diseases. Inflamm Allergy Drug Targets 2015; 14(2): 94-8.
Faust JS, Rasmussen SA, Jamieson DJ. Pregnancy should be a condition eligible for additional doses of COVID-19 messenger RNA vaccines. Am J Obstet Gynecol MFM 2023; 5(2): 100801.
Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Haas EJ, et al. Waning immunity after the BNT162b2 vaccine in Israel. N Engl J Med 2021; 385(24): e85.
Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 2021; 592(7855): 616-22.
Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2022; 22(1): 439.
The Nobel Prize. The Nobel Assembly at Karolinska Instituet: Press release [Internet]. Sweden: Nobel Prize Outreach; 2023 [cited 2023 Oct 12; accessed on 2023 Oct 23]. Available from: https://www.nobelprize.org/prizes/medicine/2023/press-release/
Liang X, Li D, Leng S, Zhu X. RNA-based pharmacotherapy for tumors: from bench to clinic and back. Biomed Pharmacoter 2020; 125: 109997.
Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 2008; 16(11): 1833-40.
Morais P, Adachi H, Yu YT. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front Cell Dev Biol 2021; 9: 789427.
Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm 2021; 601: 120586.
Ćirković MM. Natural and artificial: The cosmic Domain of Arnheim. In: Ćirković MM, editor. The astrobiological landscape: philosophical foundations of the study of cosmic life. Cambridge: Cambridge University Press; 2012. p. 184-202.
Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol 2021; 21(8): 475-84.
Matarazzo L, Bettencourt PJG. mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV. Front Immunol 2023; 14: 1172691.
Flemming A. mRNA vaccine shows promise in autoimmunity. Nat Rev Immunol 2021; 21(2): 72.
Lorentzen CL, Haanen JB, Met Ö, Svane IM. Clinical advances and ongoing trials of mRNA vaccines for cancer treatment. Lancet Oncol 2022; 23(10): e450-8. Erratum in: Lancet Oncol 2022; 23(11): e492.
Lazarus JV, Wyka K, White TM, Picchio CA, Rabin K, Ratzan SC, et al. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun 2022; 13(1): 3801.
Kafadar AH, Tekeli GG, Jones KA, Stephan B, Dening T. Determinants for COVID-19 vaccine hesitancy in the general population: a systematic review of reviews. Z Gesundh Wiss 2022; 19: 1-17.
Anderson KM, Creanza N. Internal and external factors affecting vaccination coverage: modeling the interactions between vaccine hesitancy, accessibility, and mandates. PLOS Glob Public Health 2023; 3(10): e0001186.
Olivera Mesa D, Winskill P, Ghani AC, Hauck K. The societal cost of vaccine refusal: a modelling study using measles vaccination as a case study. Vaccine 2023; 41(28): 4129-37.
Coelho P, Foster K, Nedri M, Marques MD. Increased belief in vaccination conspiracy theories predicts increases in vaccination hesitancy and powerlessness: results from a longitudinal study. Soc Sci Med 2022; 315: 115522.
Janković S. Anti-vaccine movements and scientific medicine. Biomedicinska istraživanja 2014; 5(1): 59-65. (Serbian)
Janković S. Childhood vaccination in the twenty-first century: parental concerns and challenges for physicians. Arh Farm 2019; 69: 452-68.
Banoun H. mRNA: vaccine or gene therapy? The safety regulatory issues. Int J Mol Sci 2023; 24(13): 10514.